Cargando…
Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease
The proteasome is the central component of the main cellular protein degradation pathway. During the past four decades, the critical function of the proteasome in numerous physiological processes has been revealed, and proteasome activity has been linked to various human diseases. The proteasome pre...
Autores principales: | Sherman, David J., Li, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037493/ https://www.ncbi.nlm.nih.gov/pubmed/32033280 http://dx.doi.org/10.3390/molecules25030671 |
Ejemplares similares
-
The Contribution of the 20S Proteasome to Proteostasis
por: Kumar Deshmukh, Fanindra, et al.
Publicado: (2019) -
Nuclear Ubiquitin-Proteasome Pathways in Proteostasis Maintenance
por: Franić, Dina, et al.
Publicado: (2021) -
Harnessing RKIP to Combat Heart Disease and Cancer
por: Lorenz, Kristina, et al.
Publicado: (2022) -
The effects of proteasomal inhibition on synaptic proteostasis
por: Hakim, Vicky, et al.
Publicado: (2016) -
Proteasome Activation to Combat Proteotoxicity
por: Jones, Corey L., et al.
Publicado: (2019)